An investigation was announced for investors in NASDAQ:ANGO shares. concerning potential breaches of fiduciary duties by certain AngioDynamics directors.
Investors who purchased shares of AngioDynamics, Inc. (NASDAQ:ANGO) have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain AngioDynamics directors breached their fiduciary duties.
AngioDynamics, Inc. reported that its Total Revenue declined from $356.53 million for the 52 weeks period that ended on May 31, 2015 to $353.89 million for the 12 months period that ended on May 31, 2016 and that its Net Loss increased over the same time periods from $3.39 million to $43.59 million. Shares of AngioDynamics, Inc. (NASDAQ:ANGO) grew from $10.27 per share in February 2016 to as high as $17.54 per share on September 22, 2016.
On October 6, 2106, NASDAQ:ANGO shares closed at $16.52 per share.
Those who purchased NASDAQ:ANGO shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego